Your browser doesn't support javascript.
Genetic liability between COVID-19 and heart failure: evidence from a bidirectional Mendelian randomization study.
Wang, Huachen; Guo, Zheng; Zheng, Yulu; Chen, Bing.
  • Wang H; Department of Emergency Medicine, The Second Hospital of Tianjin Medical University, Tianjin, 300211, People's Republic of China.
  • Guo Z; Centre for Precision Health, School of Medical and Health Sciences, Edith Cowan University, Perth, 6027, Australia.
  • Zheng Y; Centre for Precision Health, School of Medical and Health Sciences, Edith Cowan University, Perth, 6027, Australia.
  • Chen B; Department of Emergency Medicine, The Second Hospital of Tianjin Medical University, Tianjin, 300211, People's Republic of China. cb20202023@163.com.
BMC Cardiovasc Disord ; 22(1): 262, 2022 06 11.
Article in English | MEDLINE | ID: covidwho-1886916
ABSTRACT

BACKGROUND:

Previous studies have observed inconsistent associations between coronavirus disease 2019 (COVID-19) and heart failure (HF), but these studies were prone to bias based on reverse causality and residual confounding factors. We aimed to investigate genetic liability between COVID-19 and heart failure using a bidirectional Mendelian randomization study.

METHODS:

The causal relationship between COVID-19 (including COVID-19, hospitalized COVID-19 compared with the general population, and severe COVID-19) and HF are determined by using a bidirectional Mendelian randomization analysis. We drew on summary statistics from the largest HF genome-wide association study (GWAS) meta-analysis on individuals of European ancestry, which included 47,309 HF patients and 930,014 controls. The inverse variance weighted (IVW), an adaption of the Egger regression (MR-Egger), the weighted median, and weighted model were conducted for the Mendelian randomization analysis to estimate a causal effect. To confirm the stability, we performed a "leave-one-out" approach for the sensitivity analysis.

RESULTS:

Genetically predicted severe COVID-19 was not significantly associated with the risk of HF [odds ratio (OR), 1.003; 95% confidence interval (CI), 0.969-1.037; p = 0.867]. The IVW demonstrated that there was no association between genetically hospitalized COVID-19 infection and HF risk [OR, 1.009; 95% CI, 0.939-1.085; p = 0.797]. There was no evidence to support the association between genetically determined COVID-19 and the risk of HF [OR, 1.066; 95% CI, 0.955-1.190; p = 0.253]. In addition, genetically predicted HF was also not causally associated with COVID-19 [OR, 1.162; 95% CI, 0.824-1.639; p = 0.393]. MR-Egger analysis indicated no evidence of directional pleiotropy.

CONCLUSION:

The current bidirectional Mendelian randomization analysis overcomes the limitations of observational studies. Our findings indicated that there is no causal association between COVID-19 and HF.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Heart Failure Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Reviews Limits: Humans Language: English Journal: BMC Cardiovasc Disord Journal subject: Vascular Diseases / Cardiology Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Heart Failure Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Reviews Limits: Humans Language: English Journal: BMC Cardiovasc Disord Journal subject: Vascular Diseases / Cardiology Year: 2022 Document Type: Article